A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma

A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma

Item
http://www.wikidata.org/entity/Q33426534
Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma.IQGAP1 Scaffold-MAP Kinase Interactions Enhance Multiple Myeloma Clonogenic Growth and Self-Renewal.Selumetinib in the treatment of non-small-cell lung cancer.Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation.Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma.Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients.NRAS mutations in cutaneous T cell lymphoma (CTCL) sensitize tumors towards treatment with the multikinase inhibitor Sorafenib.The implication from RAS/RAF/ERK signaling pathway increased activation in epirubicin treated triple negative breast cancer.Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway.
P2860

A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma

Item
http://www.wikidata.org/entity/Q33426534
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A Phase II Trial of AZD6244 (S ...... ed/Refractory Multiple Myeloma
@ast
A Phase II Trial of AZD6244 (S ...... ed/Refractory Multiple Myeloma
@en
type
label
A Phase II Trial of AZD6244 (S ...... ed/Refractory Multiple Myeloma
@ast
A Phase II Trial of AZD6244 (S ...... ed/Refractory Multiple Myeloma
@en
prefLabel
A Phase II Trial of AZD6244 (S ...... ed/Refractory Multiple Myeloma
@ast
A Phase II Trial of AZD6244 (S ...... ed/Refractory Multiple Myeloma
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
A Phase II Trial of AZD6244 (S ...... ed/Refractory Multiple Myeloma
@en
P2093
P2860
P304
P31
P356
10.1158/1078-0432.CCR-15-1076
P407
P433
P478
P50
P577
P698
P921
P932